Aptose Biosciences Inc. (APTOF)
About Aptose Biosciences Inc.
APTOSE BIOSCIENCES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$25.5M
- Total assets
- $10.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Aptose Biosciences Inc. (APTOF) Stock Price
- Reported a net loss of $25.5M.
- Trading 9% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Aptose Biosciences Inc..
Write a review
Aptose Biosciences Inc.: frequently asked questions
Is Aptose Biosciences Inc. an American company?
Aptose Biosciences Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Aptose Biosciences Inc. publicly traded?
Yes — Aptose Biosciences Inc. is a publicly traded company. Its stock trades under the ticker symbol APTOF on the OTC.
What does Aptose Biosciences Inc. do?
Aptose Biosciences Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
